Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J. Nelson, Christopher B. Granger, Vanita R. Aroda et al.|Circulation|2021Cited by 79